Oramed Pharmaceuticals Ownership 2024 | Who Owns Oramed Pharmaceuticals Now?
Institutional Ownership
14.67%
Insider Ownership
11.45%
Retail Ownership
73.88%
Institutional Holders
58.00
Oramed Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MURCHINSON LTD. | 4.20% | 0.67% | 1,699,990 | 320,495 | 23.23% | 4,368,973 | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | 3.34% | 2.47% | 1,349,038 | 504,542 | 59.74% | 3,467,028 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 2.04% | 0.05% | 824,998 | 135,249 | 19.61% | 2,120,245 | Jun 30, 2024 |
| RATHBONES GROUP PLC | 0.72% | 0.00% | 289,803 | - | - | 744,794 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.57% | 0.00% | 230,800 | 108,700 | 89.03% | 593,156 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.43% | - | 173,241 | -113,811 | -39.65% | 445,230 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.37% | 0.00% | 150,367 | 15,913 | 11.84% | 386,443 | Jun 30, 2024 |
| BLACKROCK INC. | 0.22% | - | 89,706 | 411 | 0.46% | 230,545 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.20% | 0.00% | 81,758 | -7,367 | -8.27% | 210,118 | Jun 30, 2024 |
| STATE STREET CORP | 0.15% | - | 59,260 | 1,128 | 1.94% | 152,298,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.11% | - | 45,434 | 725 | 1.62% | 116,766 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.10% | 0.00% | 40,471 | -5,130 | -11.25% | 104,010 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.10% | 0.00% | 38,566 | -31,936 | -45.30% | 99,115 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.08% | - | 31,470 | 10,774 | 52.06% | 80,878 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.06% | - | 26,200 | - | - | 67,334 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.06% | - | 25,586 | 18,085 | 241.10% | 65,755 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.06% | - | 25,455 | - | - | 65,419 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.05% | - | 19,591 | - | - | 50,349 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.05% | - | 19,457 | 19,457 | 100.00% | 50,004 | Jun 30, 2024 |
| SAVVY ADVISORS, INC. | 0.05% | 0.02% | 18,810 | - | - | 48,342 | Jun 30, 2024 |
Oramed Pharmaceuticals's largest institutional shareholder is MURCHINSON LTD., holding 4.20% of the company's total share outstanding, currently valued at $4.37M. The top 10 institutional shareholders own together 12.24% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 3.34% | 2.47% | 1,349,038 | 504,542 | 59.74% | 3,467,028 | Jun 30, 2024 |
| MURCHINSON LTD. | 4.20% | 0.67% | 1,699,990 | 320,495 | 23.23% | 4,368,973 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 2.04% | 0.05% | 824,998 | 135,249 | 19.61% | 2,120,245 | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | 0.02% | 0.03% | 10,072 | 10,072 | 100.00% | 25,885 | Jun 30, 2024 |
| SAGE CAPITAL MANAGEMENT, LLC | 0.04% | 0.02% | 16,750 | - | - | 43,048 | Jun 30, 2024 |
| SAVVY ADVISORS, INC. | 0.05% | 0.02% | 18,810 | - | - | 48,342 | Jun 30, 2024 |
| GLASS JACOBSON INVESTMENT ADVISORS LLC | 0.03% | 0.01% | 10,540 | - | - | 27,088 | Jun 30, 2024 |
| RATHBONES GROUP PLC | 0.72% | 0.00% | 289,803 | - | - | 744,794 | Jun 30, 2024 |
| N.E.W. ADVISORY SERVICES LLC | 0.03% | 0.00% | 12,360 | -600 | -4.63% | 31,765 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.04% | 0.00% | 15,474 | 15,474 | 100.00% | 39,768 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.04% | 0.00% | 14,776 | -8,389 | -36.21% | 38,000 | Jun 30, 2024 |
| JOURNEY STRATEGIC WEALTH LLC | 0.03% | 0.00% | 11,000 | 552 | 5.28% | 28,270 | Jun 30, 2024 |
| ALTSHULER SHAHAM LTD | 0.03% | 0.00% | 12,020 | - | - | 30,900 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.57% | 0.00% | 230,800 | 108,700 | 89.03% | 593,156 | Jun 30, 2024 |
| CLOSE ASSET MANAGEMENT LTD | 0.03% | 0.00% | 11,400 | - | - | 29,000 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.37% | 0.00% | 150,367 | 15,913 | 11.84% | 386,443 | Jun 30, 2024 |
| MCILRATH & ECK, LLC | 0.00% | 0.00% | 2,000 | - | - | 5,140 | Jun 30, 2024 |
| ATRIA INVESTMENTS, INC | 0.04% | 0.00% | 16,611 | 16,611 | 100.00% | 42,691 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 12,389 | 9,727 | 365.40% | 31,840 | Jun 30, 2024 |
| CITY HOLDING CO | 0.00% | 0.00% | 1,070 | - | - | 2,739 | Jun 30, 2024 |
The largest Oramed Pharmaceuticals shareholder by % of total assets is BML CAPITAL MANAGEMENT, LLC. The company owns 1.35M shares of Oramed Pharmaceuticals (ORMP), representing 2.47% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 3.34% | 2.47% | 1,349,038 | 504,542 | 59.74% | 3,467,028 | Jun 30, 2024 |
| MURCHINSON LTD. | 4.20% | 0.67% | 1,699,990 | 320,495 | 23.23% | 4,368,973 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 2.04% | 0.05% | 824,998 | 135,249 | 19.61% | 2,120,245 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.57% | 0.00% | 230,800 | 108,700 | 89.03% | 593,156 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.05% | - | 19,457 | 19,457 | 100.00% | 50,004 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.06% | - | 25,586 | 18,085 | 241.10% | 65,755 | Jun 30, 2024 |
| ATRIA INVESTMENTS, INC | 0.04% | 0.00% | 16,611 | 16,611 | 100.00% | 42,691 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.37% | 0.00% | 150,367 | 15,913 | 11.84% | 386,443 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.04% | 0.00% | 15,474 | 15,474 | 100.00% | 39,768 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.08% | - | 31,470 | 10,774 | 52.06% | 80,878 | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | 0.02% | 0.03% | 10,072 | 10,072 | 100.00% | 25,885 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 12,389 | 9,727 | 365.40% | 31,840 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.01% | - | 5,081 | 5,081 | 100.00% | 13,000 | Jun 30, 2024 |
| UBS GROUP AG | 0.02% | - | 9,291 | 4,642 | 99.85% | 23,878 | Jun 30, 2024 |
| STATE STREET CORP | 0.15% | - | 59,260 | 1,128 | 1.94% | 152,298,000 | Jun 30, 2024 |
| COMPAGNIE LOMBARD ODIER SCMA | 0.00% | - | 875 | 875 | 100.00% | 2,249 | Jun 30, 2024 |
| MORGAN STANLEY | 0.11% | - | 45,434 | 725 | 1.62% | 116,766 | Jun 30, 2024 |
| JOURNEY STRATEGIC WEALTH LLC | 0.03% | 0.00% | 11,000 | 552 | 5.28% | 28,270 | Jun 30, 2024 |
| BLACKROCK INC. | 0.22% | - | 89,706 | 411 | 0.46% | 230,545 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 250 | 250 | 100.00% | 643 | Jun 30, 2024 |
As of Jun 30 2024, Oramed Pharmaceuticals's largest institutional buyer is BML CAPITAL MANAGEMENT, LLC. The company purchased 504.54K stocks of ORMP, valued at $3.47M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | 0.43% | - | 173,241 | -113,811 | -39.65% | 445,230 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 107 | -88,089 | -99.88% | 275 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.10% | 0.00% | 38,566 | -31,936 | -45.30% | 99,115 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.02% | 0.00% | 9,188 | -9,807 | -51.63% | 23,613,000 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.04% | 0.00% | 14,776 | -8,389 | -36.21% | 38,000 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.20% | 0.00% | 81,758 | -7,367 | -8.27% | 210,118 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.10% | 0.00% | 40,471 | -5,130 | -11.25% | 104,010 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.02% | - | 6,921 | -4,289 | -38.26% | 17,787 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.04% | 0.00% | 16,419 | -2,240 | -12.00% | 42,197 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.01% | - | 3,849 | -800 | -17.21% | 9,891 | Jun 30, 2024 |
| N.E.W. ADVISORY SERVICES LLC | 0.03% | 0.00% | 12,360 | -600 | -4.63% | 31,765 | Jun 30, 2024 |
| TYLER-STONE WEALTH MANAGEMENT | - | - | - | -300 | -100.00% | - | Jun 30, 2024 |
| SAGE CAPITAL MANAGEMENT, LLC | 0.04% | 0.02% | 16,750 | - | - | 43,048 | Jun 30, 2024 |
| SAVVY ADVISORS, INC. | 0.05% | 0.02% | 18,810 | - | - | 48,342 | Jun 30, 2024 |
| GLASS JACOBSON INVESTMENT ADVISORS LLC | 0.03% | 0.01% | 10,540 | - | - | 27,088 | Jun 30, 2024 |
| RATHBONES GROUP PLC | 0.72% | 0.00% | 289,803 | - | - | 744,794 | Jun 30, 2024 |
| ALTSHULER SHAHAM LTD | 0.03% | 0.00% | 12,020 | - | - | 30,900 | Jun 30, 2024 |
| CLOSE ASSET MANAGEMENT LTD | 0.03% | 0.00% | 11,400 | - | - | 29,000 | Jun 30, 2024 |
| MCILRATH & ECK, LLC | 0.00% | 0.00% | 2,000 | - | - | 5,140 | Jun 30, 2024 |
| CITY HOLDING CO | 0.00% | 0.00% | 1,070 | - | - | 2,739 | Jun 30, 2024 |
As of Jun 30 2024, Oramed Pharmaceuticals's biggest institutional seller is BANK OF AMERICA CORP /DE/. The company sold -0.11M shares of ORMP, valued at $445.23K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 0.05% | - | 19,457 | 19,457 | 100.00% | 50,004 | Jun 30, 2024 |
| ATRIA INVESTMENTS, INC | 0.04% | 0.00% | 16,611 | 16,611 | 100.00% | 42,691 | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | 0.02% | 0.03% | 10,072 | 10,072 | 100.00% | 25,885 | Jun 30, 2024 |
| COMPAGNIE LOMBARD ODIER SCMA | 0.00% | - | 875 | 875 | 100.00% | 2,249 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 250 | 250 | 100.00% | 643 | Jun 30, 2024 |
| MATHER GROUP, LLC. | 0.00% | - | 100 | 100 | 100.00% | 292 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | - | - | 13 | 13 | 100.00% | 33 | Jun 30, 2024 |
Oramed Pharmaceuticals's largest new institutional shareholder by number of shares is MILLENNIUM MANAGEMENT LLC, purchased 19.46K shares, valued at $50.00K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TYLER-STONE WEALTH MANAGEMENT | - | - | - | -300 | -100.00% | - | Jun 30, 2024 |
Oramed Pharmaceuticals's largest sold out institutional shareholder by shares sold is TYLER-STONE WEALTH MANAGEMENT, sold -0.30K shares, valued at -, as of undefined.
Oramed Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| ETF Managers Trust | 0.01% | 98,571 | - | - | Dec 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 59,243 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,624 | - | - | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.01% | 498,591 | - | - | Jan 31, 2024 |
| Nushares ETF Trust | 0.01% | 43,374 | - | - | Jan 31, 2024 |
| Federated Hermes MDT Series | 0.00% | 11,367 | - | - | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 24,182 | - | - | Aug 31, 2023 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 752 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 83,219 | - | - | Feb 29, 2024 |
| AdvisorShares Trust | 0.00% | 5,518 | - | - | Mar 28, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 13,237 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 17,948 | - | - | Jan 31, 2024 |
| CALAMOS INVESTMENT TRUST/IL | 0.00% | 85,830 | - | - | Jan 31, 2024 |
| Meeder Funds | 0.00% | 3,970 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,094 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 117,820 | - | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,278 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 12,508 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 3,686 | - | - | Mar 31, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 58,132 | 14,332 | 32.72% | Mar 31, 2024 |
| GPS Funds I | 0.00% | 1,536 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 10,444 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,060 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 19,290 | - | - | Feb 29, 2024 |
| Victory Portfolios II | 0.00% | 8,402 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 25,455 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 7,900 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 7,306 | - | - | Feb 29, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 296,130 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 798 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 278 | - | - | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 124,641 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,306 | - | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 3,283 | - | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 13,827 | - | - | Feb 29, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 15,375 | - | - | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 171 | - | - | Dec 31, 2023 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 9,088 | - | - | Feb 29, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 4,400 | -400 | -8.33% | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 212 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,000 | - | - | Mar 28, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 10,094 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 4,337 | - | - | Mar 28, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 4,056 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 90,485 | - | - | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 677 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 3,162 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 2,439 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 878 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 30 | - | - | Dec 31, 2023 |
| VANGUARD WELLINGTON FUND | 0.00% | 10,361 | - | - | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 5,387 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 20,382 | - | - | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 19,440 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 3,895 | - | - | Jan 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 1,128 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 10,953 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 27,600 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 4,114 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,092 | - | - | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 192 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 6,549 | -83 | -1.25% | Mar 31, 2024 |
| JPMorgan Trust I | 0.00% | 6,211 | - | - | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 82,746 | 1,620 | 2.00% | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 10,938 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 3,019 | - | - | Dec 31, 2023 |
| ADVANCED SERIES TRUST | 0.00% | 7,711 | - | - | Mar 28, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 228 | - | - | Jan 31, 2024 |
| Bridge Builder Trust | 0.00% | 4,650 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 5,705 | - | - | Feb 29, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 3,186 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 3,499 | - | - | Mar 28, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 697 | 96 | 15.97% | Mar 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 5,700 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 3,305 | - | - | Feb 29, 2024 |
Oramed Pharmaceuticals's largest mutual fund holder by % of total assets is "ETF Managers Trust", owning 98.57K shares, compromising 0.01% of its total assets.
Oramed Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 58 | 9.43% |
| 31 Mar, 24 | 53 | -10.17% |
| 31 Dec, 23 | 59 | 1.72% |
| 30 Sep, 23 | 58 | 9.43% |
| 30 Jun, 23 | 53 | -14.52% |
| 31 Mar, 23 | 62 | -26.19% |
| 31 Dec, 22 | 84 | 13.51% |
| 30 Sep, 22 | 74 | -17.78% |
| 30 Jun, 22 | 90 | -18.18% |
| 31 Mar, 22 | 110 | -12.70% |
| 31 Dec, 21 | 126 | 23.53% |
| 30 Sep, 21 | 102 | 25.93% |
| 30 Jun, 21 | 81 | 62.00% |
| 31 Mar, 21 | 50 | 16.28% |
| 31 Dec, 20 | 43 | 22.86% |
| 30 Sep, 20 | 35 | 2.94% |
| 30 Jun, 20 | 34 | 3.03% |
| 31 Mar, 20 | 33 | -5.71% |
| 31 Dec, 19 | 35 | 16.67% |
| 30 Sep, 19 | 30 | 15.38% |
| 30 Jun, 19 | 26 | 4.00% |
| 31 Mar, 19 | 25 | -10.71% |
| 31 Dec, 18 | 28 | - |
| 30 Sep, 18 | 28 | 33.33% |
| 30 Jun, 18 | 21 | - |
| 31 Mar, 18 | 21 | -22.22% |
| 31 Dec, 17 | 27 | 22.73% |
| 30 Sep, 17 | 22 | -4.35% |
| 30 Jun, 17 | 23 | 9.52% |
| 31 Mar, 17 | 21 | -12.50% |
| 31 Dec, 16 | 24 | 4.35% |
| 30 Sep, 16 | 23 | -20.69% |
| 30 Jun, 16 | 29 | -3.33% |
| 31 Mar, 16 | 30 | 7.14% |
| 31 Dec, 15 | 28 | 40.00% |
| 30 Sep, 15 | 20 | - |
| 30 Jun, 15 | 20 | 11.11% |
| 31 Mar, 15 | 18 | -18.18% |
| 31 Dec, 14 | 22 | 10.00% |
| 30 Sep, 14 | 20 | -20.00% |
| 30 Jun, 14 | 25 | 8.70% |
| 31 Mar, 14 | 23 | 76.92% |
| 31 Dec, 13 | 13 | 85.71% |
| 30 Sep, 13 | 7 | -12.50% |
| 30 Jun, 13 | 8 | 300.00% |
| 31 Mar, 13 | 2 | - |
As of 30 Jun 24, 58 institutions are holding Oramed Pharmaceuticals's shares, representing an increase of 9.43% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 5,933,790 | 12.77% |
| 31 Mar, 24 | 5,261,693 | 2.01% |
| 31 Dec, 23 | 5,157,843 | 124.71% |
| 30 Sep, 23 | 2,295,285 | 0.82% |
| 30 Jun, 23 | 2,276,713 | -45.14% |
| 31 Mar, 23 | 4,150,142 | 15.15% |
| 31 Dec, 22 | 3,603,975 | -7.84% |
| 30 Sep, 22 | 3,910,730 | -41.28% |
| 30 Jun, 22 | 6,660,236 | -26.19% |
| 31 Mar, 22 | 9,023,025 | 5.70% |
| 31 Dec, 21 | 8,536,686 | 35.21% |
| 30 Sep, 21 | 6,313,782 | 65.44% |
| 30 Jun, 21 | 3,816,361 | 215.52% |
| 31 Mar, 21 | 1,209,551 | -16.99% |
| 31 Dec, 20 | 1,457,043 | -27.29% |
| 30 Sep, 20 | 2,003,907 | 48.43% |
| 30 Jun, 20 | 1,350,052 | 112.42% |
| 31 Mar, 20 | 635,572 | 1.39% |
| 31 Dec, 19 | 626,872 | -17.57% |
| 30 Sep, 19 | 760,522 | -9.40% |
| 30 Jun, 19 | 839,462 | -21.79% |
| 31 Mar, 19 | 1,073,365 | -43.55% |
| 31 Dec, 18 | 1,901,342 | 9.20% |
| 30 Sep, 18 | 1,741,140 | 560.67% |
| 30 Jun, 18 | 263,540 | -4.66% |
| 31 Mar, 18 | 276,435 | -26.81% |
| 31 Dec, 17 | 377,714 | 37.46% |
| 30 Sep, 17 | 274,779 | 53.68% |
| 30 Jun, 17 | 178,804 | 20.52% |
| 31 Mar, 17 | 148,365 | 6.31% |
| 31 Dec, 16 | 139,557 | -23.24% |
| 30 Sep, 16 | 181,821 | -18.01% |
| 30 Jun, 16 | 221,770 | 10.02% |
| 31 Mar, 16 | 201,576 | -4.31% |
| 31 Dec, 15 | 210,645 | 34.33% |
| 30 Sep, 15 | 156,814 | -53.48% |
| 30 Jun, 15 | 337,104 | -38.04% |
| 31 Mar, 15 | 544,110 | -45.83% |
| 31 Dec, 14 | 1,004,534 | -27.00% |
| 30 Sep, 14 | 1,376,064 | -3.56% |
| 30 Jun, 14 | 1,426,930 | 8.78% |
| 31 Mar, 14 | 1,311,793 | 51.85% |
| 31 Dec, 13 | 863,848 | 2381.11% |
| 30 Sep, 13 | 34,817 | 51.46% |
| 30 Jun, 13 | 22,988 | -16.12% |
| 31 Mar, 13 | 27,407 | - |
Oramed Pharmaceuticals (ORMP) has 5.93M shares outstanding as of 30 Jun 24, up 12.77% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 14.67% | 8.67% |
| 31 Mar, 24 | 13.01% | 8.00% |
| 31 Dec, 23 | 12.75% | 39.17% |
| 30 Sep, 23 | 5.71% | 17.65% |
| 30 Jun, 23 | 5.69% | 5.29% |
| 31 Mar, 23 | 10.36% | 12.14% |
| 31 Dec, 22 | 9.24% | 9.24% |
| 30 Sep, 22 | 10.00% | 3.39% |
| 30 Jun, 22 | 17.17% | 3.15% |
| 31 Mar, 22 | 23.33% | 4.30% |
| 31 Dec, 21 | 23.28% | 4.73% |
| 30 Sep, 21 | 22.18% | 13.64% |
| 30 Jun, 21 | 12.75% | 63.56% |
| 31 Mar, 21 | 4.48% | 11.90% |
| 31 Dec, 20 | 6.14% | 6.44% |
| 30 Sep, 20 | 9.76% | 28.86% |
| 30 Jun, 20 | 5.82% | 45.71% |
| 31 Mar, 20 | 3.57% | 27.71% |
| 31 Dec, 19 | 3.59% | 18.90% |
| 30 Sep, 19 | 4.36% | 18.84% |
| 30 Jun, 19 | 4.81% | 12.72% |
| 31 Mar, 19 | 6.15% | 5.18% |
| 31 Dec, 18 | 10.90% | 7.96% |
| 30 Sep, 18 | 11.70% | 355.08% |
| 30 Jun, 18 | 1.82% | 49.57% |
| 31 Mar, 18 | 1.91% | 27.20% |
| 31 Dec, 17 | 2.65% | 62.23% |
| 30 Sep, 17 | 2.06% | 114.25% |
| 30 Jun, 17 | 1.34% | 107.70% |
| 31 Mar, 17 | 1.12% | 100.04% |
| 31 Dec, 16 | 1.06% | 50.94% |
| 30 Sep, 16 | 1.44% | 50.40% |
| 30 Jun, 16 | 1.69% | 66.61% |
| 31 Mar, 16 | 1.59% | 48.09% |
| 31 Dec, 15 | 1.82% | 86.67% |
| 30 Sep, 15 | 1.45% | 14.95% |
| 30 Jun, 15 | 3.11% | 12.33% |
| 31 Mar, 15 | 5.03% | 5.12% |
| 31 Dec, 14 | 9.90% | 4.47% |
| 30 Sep, 14 | 14.89% | 7.15% |
| 30 Jun, 14 | 14.43% | 6.99% |
| 31 Mar, 14 | 14.37% | 12.14% |
| 31 Dec, 13 | 10.88% | 4664.46% |
| 30 Sep, 13 | 0.48% | 476.90% |
| 30 Jun, 13 | 0.32% | 221.09% |
| 31 Mar, 13 | 0.38% | - |
As of 30 Jun 24, Oramed Pharmaceuticals is held by 14.67% institutional shareholders, representing a 8.67% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 22 | 4.76% |
| 31 Mar, 24 | 21 | -19.23% |
| 31 Dec, 23 | 26 | -3.70% |
| 30 Sep, 23 | 27 | 17.39% |
| 30 Jun, 23 | 23 | -4.17% |
| 31 Mar, 23 | 24 | -36.84% |
| 31 Dec, 22 | 38 | 58.33% |
| 30 Sep, 22 | 24 | -41.46% |
| 30 Jun, 22 | 41 | -10.87% |
| 31 Mar, 22 | 46 | -41.77% |
| 31 Dec, 21 | 79 | 17.91% |
| 30 Sep, 21 | 67 | 13.56% |
| 30 Jun, 21 | 59 | 96.67% |
| 31 Mar, 21 | 30 | 42.86% |
| 31 Dec, 20 | 21 | 40.00% |
| 30 Sep, 20 | 15 | 7.14% |
| 30 Jun, 20 | 14 | -12.50% |
| 31 Mar, 20 | 16 | 45.45% |
| 31 Dec, 19 | 11 | -8.33% |
| 30 Sep, 19 | 12 | 33.33% |
| 30 Jun, 19 | 9 | 12.50% |
| 31 Mar, 19 | 8 | -20.00% |
| 31 Dec, 18 | 10 | -28.57% |
| 30 Sep, 18 | 14 | 180.00% |
| 30 Jun, 18 | 5 | 25.00% |
| 31 Mar, 18 | 4 | -73.33% |
| 31 Dec, 17 | 15 | 25.00% |
| 30 Sep, 17 | 12 | 140.00% |
| 30 Jun, 17 | 5 | 25.00% |
| 31 Mar, 17 | 4 | -50.00% |
| 31 Dec, 16 | 8 | 33.33% |
| 30 Sep, 16 | 6 | -45.45% |
| 30 Jun, 16 | 11 | 22.22% |
| 31 Mar, 16 | 9 | -35.71% |
| 31 Dec, 15 | 14 | 75.00% |
| 30 Sep, 15 | 8 | - |
| 30 Jun, 15 | 8 | -20.00% |
| 31 Mar, 15 | 10 | -9.09% |
| 31 Dec, 14 | 11 | 57.14% |
| 30 Sep, 14 | 7 | -22.22% |
| 30 Jun, 14 | 9 | -43.75% |
| 31 Mar, 14 | 16 | 77.78% |
| 31 Dec, 13 | 9 | 200.00% |
| 30 Sep, 13 | 3 | -62.50% |
| 30 Jun, 13 | 8 | 300.00% |
| 31 Mar, 13 | 2 | - |
22 institutional shareholders have increased their position in ORMP stock as of 30 Jun 24 compared to 21 in the previous quarter (a 4.76% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 14 | - |
| 31 Mar, 24 | 14 | 27.27% |
| 31 Dec, 23 | 11 | -15.38% |
| 30 Sep, 23 | 13 | -18.75% |
| 30 Jun, 23 | 16 | -15.79% |
| 31 Mar, 23 | 19 | 5.56% |
| 31 Dec, 22 | 18 | -28.00% |
| 30 Sep, 22 | 25 | 38.89% |
| 30 Jun, 22 | 18 | -33.33% |
| 31 Mar, 22 | 27 | 58.82% |
| 31 Dec, 21 | 17 | 21.43% |
| 30 Sep, 21 | 14 | 100.00% |
| 30 Jun, 21 | 7 | 40.00% |
| 31 Mar, 21 | 5 | -44.44% |
| 31 Dec, 20 | 9 | 28.57% |
| 30 Sep, 20 | 7 | 16.67% |
| 30 Jun, 20 | 6 | -14.29% |
| 31 Mar, 20 | 7 | -30.00% |
| 31 Dec, 19 | 10 | 100.00% |
| 30 Sep, 19 | 5 | - |
| 30 Jun, 19 | 5 | 66.67% |
| 31 Mar, 19 | 3 | -50.00% |
| 31 Dec, 18 | 6 | 50.00% |
| 30 Sep, 18 | 4 | - |
| 30 Jun, 18 | 4 | -20.00% |
| 31 Mar, 18 | 5 | 66.67% |
| 31 Dec, 17 | 3 | 50.00% |
| 30 Sep, 17 | 2 | - |
| 30 Jun, 17 | 2 | -66.67% |
| 31 Mar, 17 | 6 | 20.00% |
| 31 Dec, 16 | 5 | -28.57% |
| 30 Sep, 16 | 7 | 133.33% |
| 30 Jun, 16 | 3 | -57.14% |
| 31 Mar, 16 | 7 | 75.00% |
| 31 Dec, 15 | 4 | - |
| 30 Sep, 15 | 4 | 100.00% |
| 30 Jun, 15 | 2 | - |
| 31 Mar, 15 | 2 | -60.00% |
| 31 Dec, 14 | 5 | -16.67% |
| 30 Sep, 14 | 6 | - |
| 30 Jun, 14 | 6 | 100.00% |
| 31 Mar, 14 | 3 | - |
| 31 Dec, 13 | - | -100.00% |
| 30 Sep, 13 | 1 | - |
| 30 Jun, 13 | - | - |
| 31 Mar, 13 | - | - |
14 institutional shareholders have reduced their position in ORMP stock as of 30 Jun 24 compared to 14 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 58 | 9.43% | 5,933,790 | 12.77% | 14.67% | 8.67% | 22 | 4.76% | 14 | - |
| 31 Mar, 24 | 53 | -10.17% | 5,261,693 | 2.01% | 13.01% | 8.00% | 21 | -19.23% | 14 | 27.27% |
| 31 Dec, 23 | 59 | 1.72% | 5,157,843 | 124.71% | 12.75% | 39.17% | 26 | -3.70% | 11 | -15.38% |
| 30 Sep, 23 | 58 | 9.43% | 2,295,285 | 0.82% | 5.71% | 17.65% | 27 | 17.39% | 13 | -18.75% |
| 30 Jun, 23 | 53 | -14.52% | 2,276,713 | -45.14% | 5.69% | 5.29% | 23 | -4.17% | 16 | -15.79% |
| 31 Mar, 23 | 62 | -26.19% | 4,150,142 | 15.15% | 10.36% | 12.14% | 24 | -36.84% | 19 | 5.56% |
| 31 Dec, 22 | 84 | 13.51% | 3,603,975 | -7.84% | 9.24% | 9.24% | 38 | 58.33% | 18 | -28.00% |
| 30 Sep, 22 | 74 | -17.78% | 3,910,730 | -41.28% | 10.00% | 3.39% | 24 | -41.46% | 25 | 38.89% |
| 30 Jun, 22 | 90 | -18.18% | 6,660,236 | -26.19% | 17.17% | 3.15% | 41 | -10.87% | 18 | -33.33% |
| 31 Mar, 22 | 110 | -12.70% | 9,023,025 | 5.70% | 23.33% | 4.30% | 46 | -41.77% | 27 | 58.82% |
| 31 Dec, 21 | 126 | 23.53% | 8,536,686 | 35.21% | 23.28% | 4.73% | 79 | 17.91% | 17 | 21.43% |
| 30 Sep, 21 | 102 | 25.93% | 6,313,782 | 65.44% | 22.18% | 13.64% | 67 | 13.56% | 14 | 100.00% |
| 30 Jun, 21 | 81 | 62.00% | 3,816,361 | 215.52% | 12.75% | 63.56% | 59 | 96.67% | 7 | 40.00% |
| 31 Mar, 21 | 50 | 16.28% | 1,209,551 | -16.99% | 4.48% | 11.90% | 30 | 42.86% | 5 | -44.44% |
| 31 Dec, 20 | 43 | 22.86% | 1,457,043 | -27.29% | 6.14% | 6.44% | 21 | 40.00% | 9 | 28.57% |
| 30 Sep, 20 | 35 | 2.94% | 2,003,907 | 48.43% | 9.76% | 28.86% | 15 | 7.14% | 7 | 16.67% |
| 30 Jun, 20 | 34 | 3.03% | 1,350,052 | 112.42% | 5.82% | 45.71% | 14 | -12.50% | 6 | -14.29% |
| 31 Mar, 20 | 33 | -5.71% | 635,572 | 1.39% | 3.57% | 27.71% | 16 | 45.45% | 7 | -30.00% |
| 31 Dec, 19 | 35 | 16.67% | 626,872 | -17.57% | 3.59% | 18.90% | 11 | -8.33% | 10 | 100.00% |
| 30 Sep, 19 | 30 | 15.38% | 760,522 | -9.40% | 4.36% | 18.84% | 12 | 33.33% | 5 | - |
| 30 Jun, 19 | 26 | 4.00% | 839,462 | -21.79% | 4.81% | 12.72% | 9 | 12.50% | 5 | 66.67% |
| 31 Mar, 19 | 25 | -10.71% | 1,073,365 | -43.55% | 6.15% | 5.18% | 8 | -20.00% | 3 | -50.00% |
| 31 Dec, 18 | 28 | - | 1,901,342 | 9.20% | 10.90% | 7.96% | 10 | -28.57% | 6 | 50.00% |
| 30 Sep, 18 | 28 | 33.33% | 1,741,140 | 560.67% | 11.70% | 355.08% | 14 | 180.00% | 4 | - |
| 30 Jun, 18 | 21 | - | 263,540 | -4.66% | 1.82% | 49.57% | 5 | 25.00% | 4 | -20.00% |
| 31 Mar, 18 | 21 | -22.22% | 276,435 | -26.81% | 1.91% | 27.20% | 4 | -73.33% | 5 | 66.67% |
| 31 Dec, 17 | 27 | 22.73% | 377,714 | 37.46% | 2.65% | 62.23% | 15 | 25.00% | 3 | 50.00% |
| 30 Sep, 17 | 22 | -4.35% | 274,779 | 53.68% | 2.06% | 114.25% | 12 | 140.00% | 2 | - |
| 30 Jun, 17 | 23 | 9.52% | 178,804 | 20.52% | 1.34% | 107.70% | 5 | 25.00% | 2 | -66.67% |
| 31 Mar, 17 | 21 | -12.50% | 148,365 | 6.31% | 1.12% | 100.04% | 4 | -50.00% | 6 | 20.00% |
| 31 Dec, 16 | 24 | 4.35% | 139,557 | -23.24% | 1.06% | 50.94% | 8 | 33.33% | 5 | -28.57% |
| 30 Sep, 16 | 23 | -20.69% | 181,821 | -18.01% | 1.44% | 50.40% | 6 | -45.45% | 7 | 133.33% |
| 30 Jun, 16 | 29 | -3.33% | 221,770 | 10.02% | 1.69% | 66.61% | 11 | 22.22% | 3 | -57.14% |
| 31 Mar, 16 | 30 | 7.14% | 201,576 | -4.31% | 1.59% | 48.09% | 9 | -35.71% | 7 | 75.00% |
| 31 Dec, 15 | 28 | 40.00% | 210,645 | 34.33% | 1.82% | 86.67% | 14 | 75.00% | 4 | - |
| 30 Sep, 15 | 20 | - | 156,814 | -53.48% | 1.45% | 14.95% | 8 | - | 4 | 100.00% |
| 30 Jun, 15 | 20 | 11.11% | 337,104 | -38.04% | 3.11% | 12.33% | 8 | -20.00% | 2 | - |
| 31 Mar, 15 | 18 | -18.18% | 544,110 | -45.83% | 5.03% | 5.12% | 10 | -9.09% | 2 | -60.00% |
| 31 Dec, 14 | 22 | 10.00% | 1,004,534 | -27.00% | 9.90% | 4.47% | 11 | 57.14% | 5 | -16.67% |
| 30 Sep, 14 | 20 | -20.00% | 1,376,064 | -3.56% | 14.89% | 7.15% | 7 | -22.22% | 6 | - |
| 30 Jun, 14 | 25 | 8.70% | 1,426,930 | 8.78% | 14.43% | 6.99% | 9 | -43.75% | 6 | 100.00% |
| 31 Mar, 14 | 23 | 76.92% | 1,311,793 | 51.85% | 14.37% | 12.14% | 16 | 77.78% | 3 | - |
| 31 Dec, 13 | 13 | 85.71% | 863,848 | 2381.11% | 10.88% | 4664.46% | 9 | 200.00% | - | -100.00% |
| 30 Sep, 13 | 7 | -12.50% | 34,817 | 51.46% | 0.48% | 476.90% | 3 | -62.50% | 1 | - |
| 30 Jun, 13 | 8 | 300.00% | 22,988 | -16.12% | 0.32% | 221.09% | 8 | 300.00% | - | - |
| 31 Mar, 13 | 2 | - | 27,407 | - | 0.38% | - | 2 | - | - | - |
Oramed Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
All Insider Owners Trades
Oramed Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 3 | - | - |
| Q1 2024 | 15 | - | - |
| Q2 2023 | 16 | - | - |
| Q1 2023 | 4 | 3 | 133.33% |
| Q4 2022 | - | 1 | - |
| Q3 2022 | 11 | 3 | 366.67% |
| Q2 2022 | 1 | - | - |
| Q1 2022 | 26 | 9 | 288.89% |
| Q4 2021 | - | 6 | - |
| Q3 2021 | 13 | 11 | 118.18% |
| Q1 2021 | 5 | 1 | 500.00% |
| Q1 2020 | 7 | - | - |
| Q4 2019 | - | 1 | - |
| Q3 2019 | 12 | 1 | 1200.00% |
| Q2 2019 | 3 | 2 | 150.00% |
| Q1 2019 | 4 | 2 | 200.00% |
| Q4 2018 | - | - | - |
| Q3 2018 | 3 | 1 | 300.00% |
| Q2 2018 | 2 | - | - |
| Q1 2018 | 3 | - | - |
3 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Oramed Pharmaceuticals's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q2 2023 | 2 | - | - |
| Q1 2023 | 4 | 3 | 133.33% |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | 1 | - |
| Q4 2021 | - | 1 | - |
| Q3 2021 | - | 3 | - |
| Q1 2021 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | 7 | - | - |
| Q2 2019 | - | - | - |
| Q1 2019 | - | - | - |
| Q4 2018 | - | - | - |
| Q3 2018 | 3 | 1 | 300.00% |
| Q2 2018 | - | - | - |
| Q1 2018 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Oramed Pharmaceuticals's stocks.
Oramed Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| LXRX | Lexicon Pharmaceuticals, Inc. |
| CKPT | Checkpoint Therapeutics, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| GMDA | Gamida Cell Ltd. |
| CWBR | CohBar, Inc. |
| MREO | Mereo BioPharma Group plc |
| ALDX | Aldeyra Therapeutics, Inc. |
| BLRX | BioLineRx Ltd. |
| CRVS | Corvus Pharmaceuticals, Inc. |
| MCRB | Seres Therapeutics, Inc. |
| ARDX | Ardelyx, Inc. |
| AVRO | AVROBIO, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| IBRX | ImmunityBio, Inc. |
| IMMX | Immix Biopharma, Inc. |
| CYTO | Altamira Therapeutics Ltd. |
| OCEA | Ocean Biomedical, Inc. |
| LPTX | Leap Therapeutics, Inc. |
| HEPA | Hepion Pharmaceuticals, Inc. |
| ZURA | Zura Bio Limited |
| ELEV | Elevation Oncology, Inc. |
| ENVB | Enveric Biosciences, Inc. |
| PALI | Palisade Bio, Inc. |
ORMP Ownership FAQ
Who Owns Oramed Pharmaceuticals?
Oramed Pharmaceuticals is owned by institutional shareholders (14.67%), insiders (11.45%), and public (73.88%). The largest institutional shareholder of Oramed Pharmaceuticals is MURCHINSON LTD. (4.20% of total shares) and the top mutual fund owner is ETF Managers Trust (0.01% of total shares).
Who are the major institutional shareholders of Oramed Pharmaceuticals?
Oramed Pharmaceuticals's major institutional shareholders are MURCHINSON LTD., BML CAPITAL MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, RATHBONES GROUP PLC, and RENAISSANCE TECHNOLOGIES LLC. The top five shareholders own together 10.87% of the company's share outstanding.
How many Oramed Pharmaceuticals shareholders are there?
As of Jun 2024, there are 58 institutional shareholders of Oramed Pharmaceuticals.
What percentage of Oramed Pharmaceuticals is owned by MURCHINSON LTD?
MURCHINSON LTD owns 1.7M shares of Oramed Pharmaceuticals, representing 4.20% of the company's total shares outstanding, valued at $4.37M (as of Jun 2024).
What percentage of Oramed Pharmaceuticals is owned by BML CAPITAL MANAGEMENT, LLC?
As of Jun 2024, BML CAPITAL MANAGEMENT, LLC holds 1.35M shares of Oramed Pharmaceuticals (ORMP), compromising 3.34% of the company, valued at $3.47M.
What percentage of Oramed Pharmaceuticals is owned by BOOTHBAY FUND MANAGEMENT, LLC?
BOOTHBAY FUND MANAGEMENT, LLC is the third largest holder of Oramed Pharmaceuticals. The company owns 825K of the company's shares outstanding (worth $2.12M).